JN Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Neurophysiol 84: 1697-1707, 2000;
0022-3077/00 $5.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Feigenspan, A.
Right arrow Articles by Raviola, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Feigenspan, A.
Right arrow Articles by Raviola, E.

The Journal of Neurophysiology Vol. 84 No. 4 October 2000, pp. 1697-1707
Copyright ©2000 by the American Physiological Society

Pharmacology of GABAA Receptors of Retinal Dopaminergic Neurons

Andreas Feigenspan, Stefano Gustincich, and Elio Raviola

Department of Neurobiology, Harvard Medical School, Boston, Massachusetts 02115

Feigenspan, Andreas, Stefano Gustincich, and Elio Raviola. Pharmacology of GABAA Receptors of Retinal Dopaminergic Neurons. J. Neurophysiol. 84: 1697-1707, 2000. When the vertebrate retina is stimulated by light, a class of amacrine or interplexiform cells release dopamine, a modulator responsible for neural adaptation to light. In the intact retina, dopamine release can be pharmacologically manipulated with agonists and antagonists at GABAA receptors, and dopaminergic (DA) cells receive input from GABAergic amacrines. Because there are only 450 DA cells in each mouse retina and they cannot be distinguished in the living state from other cells on the basis of their morphology, we used transgenic technology to label DA cells with human placental alkaline phosphatase, an enzyme that resides on the outer surface of the cell membrane. We could therefore identify DA cells in vitro after dissociation of the retina and investigate their activity with whole cell voltage clamp. We describe here the pharmacological properties of the GABAA receptors of solitary DA cells. GABA application induces a large inward current carried by chloride ions. The receptors are of the GABAA type because the GABA-evoked current is blocked by bicuculline. Their affinity for GABA is very high with an EC50 value of 7.4 µM. Co-application of benzodiazepine receptor ligands causes a strong increase in the peak current induced by GABA (maximal enhancement: CL-218872 220%; flunitrazepam 214%; zolpidem 348%) proving that DA cells express a type I benzodiazepine-receptor (BZ1). GABA-evoked currents are inhibited by Zn2+ with an IC50 of 58.9 ± 8.9 µM. Furthermore, these receptors are strongly potentiated by the modulator alphaxalone with an EC50 of 340 ± 4 nM. The allosteric modulator loreclezole increases GABA receptor currents by 43% (1 µM) and by 107% (10 µM). Using outside-out patches, we measured in single-channel recordings a main conductance (29 pS) and two subconductance (20 and 9 pS) states. We have previously shown by single-cell RT-PCR and immunocytochemistry that DA cells express seven different GABAA receptor subunits (alpha 1, alpha 3, alpha 4, beta 1, beta 3, gamma 1, gamma 2S, and gamma 2L) and by immunocytochemistry that all subunits are expressed in the intact retina. We show here that at least alpha 1, beta 3 and gamma 2 subunits are assembled into functional receptors.




This article has been cited by other articles:


Home page
J. Neurosci.Home page
S. Maxeiner, K. Dedek, U. Janssen-Bienhold, J. Ammermuller, H. Brune, T. Kirsch, M. Pieper, J. Degen, O. Kruger, K. Willecke, et al.
Deletion of Connexin45 in Mouse Retinal Neurons Disrupts the Rod/Cone Signaling Pathway between AII Amacrine and ON Cone Bipolar Cells and Leads to Impaired Visual Transmission
J. Neurosci., January 19, 2005; 25(3): 566 - 576.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
P. Witkovsky, E. Veisenberger, J. W. Haycock, A. Akopian, A. Garcia-Espana, and E. Meller
Activity-Dependent Phosphorylation of Tyrosine Hydroxylase in Dopaminergic Neurons of the Rat Retina
J. Neurosci., April 28, 2004; 24(17): 4242 - 4249.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
J. Verweij, E. P. Hornstein, and J. L. Schnapf
Surround Antagonism in Macaque Cone Photoreceptors
J. Neurosci., November 12, 2003; 23(32): 10249 - 10257.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
G. Lowe
Inhibition of Backpropagating Action Potentials in Mitral Cell Secondary Dendrites
J Neurophysiol, July 1, 2002; 88(1): 64 - 85.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online